Prevention of Enteric Diseases
- 1 January 2004
- book chapter
- Published by Springer Nature
- Vol. 549, 71-82
- https://doi.org/10.1007/978-1-4419-8993-2_11
Abstract
Estimates of diarrheal disease mortality suggest that at least 2 million persons succumb annually to diarrhea, and in countless others, the infections aggravate malnutrition and its attendant ills. Though enteric diseases are nearly always spread by the fecal-oral route, prevention of enteric illness by improvement of water and food quality is impractical in most developing countries. Yet, the diversity of enteric pathogens presents a formidable obstacle to prevention by more specific means, such as vaccination. We would argue, however, that for certain specific infections, immunization is both feasible and the most efficient means of prevention. Calculations of disease burden can assist in identifying problems for which specific interventions should be pursued. We review four enteric infections for which vaccine development strategies have received wide attention. However, in none of these cases is a cheap and effective vaccine yet available.Keywords
This publication has 91 references indexed in Scilit:
- Escherichia coli O157:H7Gastroenterology Clinics of North America, 2001
- Misleading Negative Findings in a Field Trial of Killed, Oral Cholera Vaccine in PeruThe Journal of Infectious Diseases, 2001
- Two‐Year Study of the Protective Efficacy of the Oral Whole Cell plus Recombinant B Subunit Cholera Vaccine in PeruThe Journal of Infectious Diseases, 2000
- Oral immunization of mice with a glycoconjugate vaccine containing the O157 antigen ofEscherichia coliO157:H7 admixed with cholera toxin fails to elicit protection against subsequent colonization by the pathogenCanadian Journal of Microbiology, 2000
- Immunosuppression by a corticosteroid fails to exacerbate Helicobacter pylori infection in a mouse model of gastric colonizationCanadian Journal of Microbiology, 1999
- Salmonella landau as a live vaccine against Escherichia coli O157:H7 investigated in a mouse model of intestinal colonizationCanadian Journal of Microbiology, 1999
- Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgRThe Journal of Infectious Diseases, 1992
- Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian childrenThe Lancet, 1992
- Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in ThailandThe Journal of Infectious Diseases, 1992
- OmpB (osmo-regulation) and icsA (cell-to-cell spread) mutants of Shigella flexneri: vaccine candidates and probes to study the pathogenesis of shigellosisVaccine, 1991